VENTREX COATED TUBE INTACT PTH— 510(k) K913434

Name: FDA 510(k) clearance K913434
Creator: U.S. Food and Drug Administration
Published: 1991-10-25

Substantially Equivalent

Ventrex Laboratories, Inc.

FDA 510(k) clearance K913434 for VENTREX COATED TUBE INTACT PTH, Substantially Equivalent on 1991-10-25. Applicant: Ventrex Laboratories, Inc.. Device class: 2.

Clearance details

Applicant: Ventrex Laboratories, Inc.
Product code: Code CEW
Device class: Class 2
Regulation: 21 CFR 862.1545
Advisory panel: Clinical Chemistry
Date received: 1991-08-01
Decision date: 1991-10-25
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Portland, ME, US

Download summary PDF View on FDA.gov ↗

Recent devices under product code CEW

view all

K231927 — Elecsys PTH , Elecsys PTH STAT2024-03-22
K232791 — Access Intact PTH2024-03-01
K221197 — VITROS Immunodiagnostic Products Intact PTH II Reagent Pack2023-09-05
K190702 — Lumipulse G whole PTH2019-08-30
K163658 — ADVIA Centaur Intact Parathyroid Hormone (PTH) Assay2017-05-23

More clearances from Ventrex Laboratories, Inc.

view all

K914554 — SPECIFIC IGE EIA-TURBO ASSAY1992-03-13
K913833 — VENTREX ALLERGEN DISC1992-02-21
K905612 — VENTREX COATED TUBE IGE RADIOIMMUNOASSAY1991-02-21
K905636 — VENTREX COATED TUBE IGE ENZYME IMMUNOASSAY1991-02-07
K905247 — SHBG IRMA KIT1991-01-17

Adverse events under product code CEW

product code CEW

Malfunction: 480
Total: 480

Source: openFDA MAUDE database, 2020-01-01 through 2026-04-23. Counts aggregate all devices under this product code, not just this specific clearance. Reports are submissions to FDA, not validated events. Search MAUDE directly →

Data sourced from openFDA. This site is unofficial and independent of the FDA.